TAILIEUCHUNG - Seroquel: Highlights Of Prescribing Information

Access to basic services and mobility are both enhanced by public transportation and street connectivity (., streets lead to other streets and stores, rather than just ending in cul-de-sacs). Having access to a car, or the use of mass transit, may enable greater mobility and utilization of local resources. Street connectivity may result in smaller walkable neighborhoods and create the opportunity to walk, both recreationally and to complete necessary errands independently. Research has demonstrated that people walk more when they live in communities that have greater housing and population density and more street connectivity. This, in turn, enhances opportunities for. | 1657600 SEROQUEL quetiapine fumarate TABLETS HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the Information needed to use SEROQUEL safely and effectively. See full Prescribing Information for SEROQUEL. SEROQUEL quetiapine fumarate Tablets Initial US Approval 1997 WARNING INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS See full Prescribing Information tor complete boxed warning. Antipsychotic drugs are associated with an increased risk of death Quetiapine is not approved for elderly patients with Dementia-Related Psychosis WARNING SUICIDALITY AND ANTIDEPRESSANT DRUGS See full Prescribing Information tor complete boxed warning. Increased risk of suicidal thinking and behavior in children adolescents and young adults taking antidepressants for major depressive disorder and other psychiatric disorders .RECENT MAJOR CHANGES. Warnings and Precautions Hyperglycemia 1 2011 Warnings and Precautions Hyperlipidemia 1 2011 Warnings and Precautions Weight Gain 1 2011 Warnings and Precautions QT Prolongation 7 2011 Warnings and Precautions Hypothyroidism 1 2011 - - - - - - INDICATIONS AND USAGE. SEROQUEL is an atypical antipsychotic indicated for the Treatment of schizophrenia Adults Efficacy was established in three 6-week clinical trials in patients with schizophrenia Adolescents ages 13-17 Efficacy was established in one 6-week trial in patients with schizophrenia Acute treatment of manic episodes associated with bipolar I disorder both as monotherapy and as an adjunct to lithium or divalproex Adults Efficacy was established in two 12-week monotherapy trials and in one 3-week adjunctive trial in patients with manic episodes associated with bipolar I disorder Children and Adolescents ages 10-17 Efficacy was established in one 3-week monotherapy trial in patients with manic episodes associated with bipolar I disorder Acute treatment of depressive episodes .

• Sức khỏe người cao tuổi
• increasing possibility
• treatment and research
• adequate supply
• Phosphorylation State
• Seawater Fish Spermatozoa
• Current Issues
• Research recommendations
• Full guideline
• Quick reference guide
• Steinman discovered
• memory against
• Steinman demonstrated